The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995
Abstract
We treated four patients with acromegaly for 8 to 24 weeks with SMS 201-995, the long-acting somatostatin analogue, in dosages of 100 to 300 micrograms a day given subcutaneously. A rapid amelioration of the clinical signs and symptoms and near normalization of laboratory test results occurred in all patients. Mean plasma growth hormone concentrations (+/- S.E.M.), as measured over 24 hours, fell from an initial value of 57 +/- 18 micrograms per liter to 7.5 +/- 2 micrograms per liter at the end of the investigational period. Likewise, levels of plasma somatomedin-C, which were originally elevated in all patients, dropped to the normal or nearly normal range. The suppression of insulin secretion and the resulting hyperglycemia that were observed at the beginning of treatment became less marked as therapy progressed. There was evidence of slight tumor shrinkage in three of the subjects. No side effects were recorded throughout the treatment period. These preliminary results suggest that SMS 201-995 represents an additional option for the management of acromegaly, especially in patients who do not benefit sufficiently from surgery or radiotherapy and do not respond well to treatment with dopaminergic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C
Clemmons, D. R., Van Wyk, J. J., Ridgway, E. C., Kliman, B., Kjellberg, R. N., & Underwood, L. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911223012102 · Cited by 364
Long-term treatment of acromegaly with bromocriptine.
Wass, J. A., Thorner, M. O., Morris, D. V., Rees, L. H., Mason, A. S., Jones, A. E., & Besser, G. M. (1977) · BMJ · doi:10.1136/bmj.1.6065.875 · Cited by 242
Plewe, G., Krause, U., Beyer, J., Neufeld, M., & del Pozo, E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90706-2 · Cited by 191
Self-citationYen, S. S. C., Siler, T. M., & De Vane, G. W. (1974) · New England Journal of Medicine · doi:10.1056/nejm197404252901704 · Cited by 188
WASS, J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90120-x · Cited by 166
PIETERS, G. F. F. M., ROMEIJN, J. E., SMALS, A. G. H., & KLOPPENBORG, P. W. C. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-5-942 · Cited by 38
New Criteria for Evaluation of Acromegaly
Daughaday, W. H. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911223012109 · Cited by 32
Bromocriptine therapy in acromegaly. A long-term review of 35 cases
Sachdev, Y., Gopal, K., & Garg, V. K. (1981) · Postgraduate Medical Journal · doi:10.1136/pgmj.57.666.210 · Cited by 14
Cited by
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199312441 · Cited by 784
SACCÀ, L., CITTADINI, A., & FAZIO, S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-555 · Cited by 543
Melmed, S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221405 · Cited by 438
Metadata
- Authors
- Lamberts, S. W. J., Uitterlinden, P., Verschoor, L., van Dongen, K. J., & del Pozo, E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1985-12-19
- Volume
- 313
- Issue
- 25
- Pages
- 1576-1580
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2339145711
- Cited by
- 397
- References
- 9
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995. https://app.cochat.ai/papers/10.1056/nejm198512193132504
- The paper
- Lamberts, S. W. J., Uitterlinden, P., Verschoor, L., van Dongen, K. J., & del Pozo, E. (1985). Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995. New England Journal of Medicine. https://doi.org/10.1056/nejm198512193132504
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.